Fluconazole
DrugFluconazole oral suspension 6 mg/kg/day for 6 weeks followed by 4 weeks without treatment
NCT Number: NCT00645242
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Looking for future studies?
Notify Me3 year–12 year
All sexes
Interventional
Phase 3
Pfizer Investigational Site, Carolina, Puerto Rico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fluconazole oral suspension 6 mg/kg/day for 6 weeks followed by 4 weeks without treatment
Time frame: Week 6
Time frame: Weeks 3, 6, and 10
Time frame: Weeks 3 and 10
Time frame: Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
Pfizer
Industry
An Open Label, Multicenter Trial Of Diflucan (Fluconazole) For 6 Weeks Given Once Daily To Pediatric Patients With Tinea Capitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07043582
Bacterial Infections and Mycoses, Dermatomycoses
Istanbul, Kadıköy, Turkey (Türkiye)
View Trial DetailsNCT07068256
Bacterial Infections and Mycoses, Dermatomycoses
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT04144491
Bacterial Infections and Mycoses, Common Cold
Kabwohe, Sheema, Uganda
View Trial DetailsNCT02550496
Bacterial Infections and Mycoses, Dermatomycoses
Amiens, Picardie, France
View Trial Details